Viking Therapeutics
VKTX
$76.97
Share price
1.60%
Change (1 day)
236.70%
Change (1 year)
Categories
Viking Therapeutics (VKTX) - Total debt
Total debt on the balance sheet as of March 2024 : $1.18 M
According to Viking Therapeutics 's latest financial reports the company's total debt is $1.18 M. A company’s total debt is the sum of all current and non-current debts.
Viking Therapeutics - Total debt on balance sheet (from 2014 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.26 M | -19.44% |
| 2022-12-31 | $1.56 M | 5293.1% |
| 2021-12-31 | $0.02 M | -91.92% |
| 2020-12-31 | $0.35 M | -45.77% |
| 2019-12-31 | $0.66 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $3.45 M | 5.55% |
| 2016-12-31 | $3.26 M | 51.96% |
| 2015-12-31 | $2.15 M | 37.18% |
| 2014-12-31 | $1.56 M | 462.66% |
| 2013-12-31 | $0.27 M | 552.04% |
| 2012-12-31 | $0.04 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | $43.16 M | 3,555.29% | 🇺🇸 USA |
 Repligen
RGEN | $0.71 B | 60,171.30% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |